Demethylating therapy increases cytotoxicity of CD44v6 CAR-T cells against acute myeloid leukemia

BACKGROUND: CD44v6 chimeric antigen receptor T (CD44v6 CAR-T) cells demonstrate strong anti-tumor ability and safety in acute myeloid leukemia (AML). However, the expression of CD44v6 on T cells leads to transient fratricide and exhaustion of CD44v6 CAR-T cells, which affect the application of CD44v...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Ling, Kong, Yingjie, Wang, Haobing, Zou, Ping, Sun, Ting, Liu, Ying, Zhang, Juan, Jin, Na, Mao, Hanwen, Zhu, Xiaojian, Wang, Jue, Meng, Fankai, You, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174291/
https://www.ncbi.nlm.nih.gov/pubmed/37180104
http://dx.doi.org/10.3389/fimmu.2023.1145441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174291/
https://www.ncbi.nlm.nih.gov/pubmed/37180104
http://dx.doi.org/10.3389/fimmu.2023.1145441

Ejemplares similares